Teleflex (NYSE:TFX) Reaches New 12-Month High – Time to Buy?

Shares of Teleflex Incorporated (NYSE:TFX) hit a new 52-week high on Wednesday. The stock traded as high as $147.99 and last traded at $144.9860, with a volume of 20,802 shares trading hands. The stock had previously closed at $139.95.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on TFX shares. Weiss Ratings restated a “sell (d)” rating on shares of Teleflex in a research report on Monday, September 21st. UBS Group increased their target price on shares of Teleflex from $145.00 to $158.00 and gave the company a “neutral” rating in a research report on Tuesday, August 11th. Truist Financial decreased their target price on shares of Teleflex from $150.00 to $142.00 and set a “hold” rating for the company in a research report on Wednesday, October 14th. Mizuho raised their price target on shares of Teleflex from $140.00 to $145.00 and gave the stock a “neutral” rating in a report on Wednesday, July 15th. Finally, Needham & Company LLC boosted their price target on shares of Teleflex from $159.00 to $170.00 and gave the stock a “buy” rating in a research report on Tuesday, August 25th. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $154.40.

Teleflex Stock Performance

The firm has a market capitalization of $6.20 billion, a P/E ratio of -6.27, a P/E/G ratio of 0.94 and a beta of 0.85. The stock has a fifty day simple moving average of $131.43 and a two-hundred day simple moving average of $125.37. The company has a debt-to-equity ratio of 0.94, a current ratio of 2.60 and a quick ratio of 2.12.

Teleflex (NYSE:TFX) last issued its quarterly earnings results on Thursday, August 6th. The medical technology company reported $1.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.28 by $0.48. The firm had revenue of $570.33 million for the quarter, compared to analyst estimates of $559.59 million. Teleflex had a positive return on equity of 11.93% and a negative net margin of 39.67%. The company’s revenue was up 28.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $3.73 earnings per share. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. On average, research analysts predict that Teleflex Incorporated will post 7.22 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. BlackRock Inc. bought a new stake in shares of Teleflex during the second quarter valued at approximately $688,537,000. Jupiter Topco LLC acquired a new position in shares of Teleflex during the second quarter worth approximately $550,456,000. Janus Henderson Group PLC raised its position in shares of Teleflex by 1.1% during the first quarter. Janus Henderson Group PLC now owns 4,291,311 shares of the medical technology company’s stock worth $513,281,000 after purchasing an additional 45,199 shares during the period. Irenic Capital Management LP acquired a new stake in Teleflex in the 1st quarter valued at $104,061,000. Finally, Pzena Investment Management LLC acquired a new stake in Teleflex in the 2nd quarter valued at $76,462,000. 95.62% of the stock is owned by institutional investors.

About Teleflex

Teleflex Incorporated is a global medical technology company that develops, manufactures and markets specialty medical devices. Its products are designed to support healthcare professionals in critical care and procedural settings, including vascular access, interventional cardiology and radiology, anesthesia, respiratory care, emergency medicine, surgical applications and urology.

The company’s portfolio includes catheters, access and closure devices, airway-management products, surgical instruments, pain-management devices and other technologies used in hospitals and outpatient facilities.